Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion type Assertion NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_head.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_provenance.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion evidence source_evidence_literature NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_provenance.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion SIO_000772 16232198 NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_provenance.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion wasDerivedFrom befree-20140225 NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_provenance.
- NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_assertion wasGeneratedBy ECO_0000203 NP665657.RAJnBdEb4cllKPL60Qk1V4297XRWqMVGUWRXI6Sxh_PlY130_provenance.